BR112018075433A2 - derivados de piperidinila, processo para sua preparação e composições farmacêuticas contendo-os - Google Patents

derivados de piperidinila, processo para sua preparação e composições farmacêuticas contendo-os

Info

Publication number
BR112018075433A2
BR112018075433A2 BR112018075433-1A BR112018075433A BR112018075433A2 BR 112018075433 A2 BR112018075433 A2 BR 112018075433A2 BR 112018075433 A BR112018075433 A BR 112018075433A BR 112018075433 A2 BR112018075433 A2 BR 112018075433A2
Authority
BR
Brazil
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
piperidinyl derivatives
Prior art date
Application number
BR112018075433-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Kotschy ANDRÁS
Wéber Csaba
Vasas Attila
Molnár Balázs
Kiss Árpád
Macias Alba
Brooke Murray James
Lewkowicz Elodie
Geneste Olivier
Chanrion Maïa
Demarles Didier
Original Assignee
Les Laboratoires Servier
Vernalis (R&D) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier, Vernalis (R&D) Limited filed Critical Les Laboratoires Servier
Publication of BR112018075433A2 publication Critical patent/BR112018075433A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR112018075433-1A 2016-06-10 2017-06-09 derivados de piperidinila, processo para sua preparação e composições farmacêuticas contendo-os BR112018075433A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1655392 2016-06-10
FR1655392A FR3052452B1 (fr) 2016-06-10 2016-06-10 Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/EP2017/064067 WO2017212012A1 (en) 2016-06-10 2017-06-09 New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
BR112018075433A2 true BR112018075433A2 (pt) 2019-03-19

Family

ID=56943687

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018075433-1A BR112018075433A2 (pt) 2016-06-10 2017-06-09 derivados de piperidinila, processo para sua preparação e composições farmacêuticas contendo-os

Country Status (46)

Country Link
US (1) US11046681B2 (cg-RX-API-DMAC10.html)
EP (1) EP3468974B1 (cg-RX-API-DMAC10.html)
JP (1) JP6928005B2 (cg-RX-API-DMAC10.html)
KR (1) KR20190016106A (cg-RX-API-DMAC10.html)
CN (1) CN109311888B (cg-RX-API-DMAC10.html)
AR (1) AR108706A1 (cg-RX-API-DMAC10.html)
AU (1) AU2017277734B2 (cg-RX-API-DMAC10.html)
BR (1) BR112018075433A2 (cg-RX-API-DMAC10.html)
CA (1) CA3027014C (cg-RX-API-DMAC10.html)
CL (1) CL2018003474A1 (cg-RX-API-DMAC10.html)
CO (1) CO2018013210A2 (cg-RX-API-DMAC10.html)
CR (1) CR20180564A (cg-RX-API-DMAC10.html)
CU (1) CU20180145A7 (cg-RX-API-DMAC10.html)
CY (1) CY1122870T1 (cg-RX-API-DMAC10.html)
DK (1) DK3468974T3 (cg-RX-API-DMAC10.html)
DO (1) DOP2018000270A (cg-RX-API-DMAC10.html)
EA (1) EA037211B1 (cg-RX-API-DMAC10.html)
EC (1) ECSP18090144A (cg-RX-API-DMAC10.html)
ES (1) ES2775789T3 (cg-RX-API-DMAC10.html)
FR (1) FR3052452B1 (cg-RX-API-DMAC10.html)
GE (2) GEP20207160B (cg-RX-API-DMAC10.html)
HR (1) HRP20200361T1 (cg-RX-API-DMAC10.html)
HU (1) HUE049507T2 (cg-RX-API-DMAC10.html)
IL (1) IL263463B (cg-RX-API-DMAC10.html)
LT (1) LT3468974T (cg-RX-API-DMAC10.html)
MA (1) MA45222B1 (cg-RX-API-DMAC10.html)
MD (1) MD3468974T2 (cg-RX-API-DMAC10.html)
ME (1) ME03670B (cg-RX-API-DMAC10.html)
MX (1) MX374794B (cg-RX-API-DMAC10.html)
MY (1) MY196562A (cg-RX-API-DMAC10.html)
NI (1) NI201800132A (cg-RX-API-DMAC10.html)
NZ (1) NZ748946A (cg-RX-API-DMAC10.html)
PE (1) PE20220567A1 (cg-RX-API-DMAC10.html)
PH (1) PH12018502515B1 (cg-RX-API-DMAC10.html)
PL (1) PL3468974T3 (cg-RX-API-DMAC10.html)
PT (1) PT3468974T (cg-RX-API-DMAC10.html)
RS (1) RS60029B1 (cg-RX-API-DMAC10.html)
RU (1) RU2743163C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201810629QA (cg-RX-API-DMAC10.html)
SI (1) SI3468974T1 (cg-RX-API-DMAC10.html)
SV (1) SV2018005791A (cg-RX-API-DMAC10.html)
TN (1) TN2018000410A1 (cg-RX-API-DMAC10.html)
TW (1) TWI620750B (cg-RX-API-DMAC10.html)
UA (1) UA123794C2 (cg-RX-API-DMAC10.html)
UY (1) UY37288A (cg-RX-API-DMAC10.html)
WO (1) WO2017212012A1 (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102398439B1 (ko) 2016-03-07 2022-05-16 이난타 파마슈티칼스, 인코포레이티드 B형 간염 항바이러스제
WO2018195450A1 (en) 2017-04-21 2018-10-25 Epizyme, Inc. Combination therapies with ehmt2 inhibitors
SG11202001685TA (en) 2017-08-28 2020-03-30 Enanta Pharm Inc Hepatitis b antiviral agents
TW201925202A (zh) * 2017-11-29 2019-07-01 法商施維雅藥廠 新穎哌啶基衍生物、其製備方法及含其之醫藥組合物
GB201801562D0 (en) 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds
UY38291A (es) * 2018-07-05 2020-06-30 Servier Lab Nuevos derivados de amino-pirimidonilo un proceso para su preparación y composiciones farmacéuticas
TW202024093A (zh) 2018-09-21 2020-07-01 美商安塔製藥公司 作為抗病毒劑之官能化雜環
UY38423A (es) * 2018-10-19 2021-02-26 Servier Lab Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
EP3883570A4 (en) 2018-11-21 2022-07-13 Enanta Pharmaceuticals, Inc. FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS
US20220033397A1 (en) * 2018-12-06 2022-02-03 Almac Discovery Limited Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)
WO2020247444A1 (en) 2019-06-03 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
WO2020247561A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
US11472808B2 (en) 2019-06-04 2022-10-18 Enanta Pharmaceuticals, Inc. Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
WO2021007488A1 (en) 2019-07-11 2021-01-14 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2021055425A2 (en) 2019-09-17 2021-03-25 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
CN113087718B (zh) * 2020-01-09 2024-02-09 四川科伦博泰生物医药股份有限公司 噻吩并嘧啶酮类化合物及其医药应用
CN112608320B (zh) * 2020-01-16 2023-03-17 中国药科大学 哌啶类化合物及其制备方法和医药用途
GB202001980D0 (en) 2020-02-13 2020-04-01 Almac Discovery Ltd Therapeutic mentods
US11802125B2 (en) 2020-03-16 2023-10-31 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2634235A1 (en) * 2005-12-21 2007-07-05 Schering Corporation Combination of an h3 antagonist/inverse agonist and an appetite suppressant
CA2679807A1 (en) * 2007-03-02 2008-09-12 Schering Corporation Piperidine derivatives and methods of use thereof
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
PL3468971T3 (pl) * 2016-06-10 2020-08-10 Les Laboratoires Servier Nowe pochodne (hetero)arylo-piperydynylowe, sposoby ich wytwarzania oraz zawierające je kompozycje

Also Published As

Publication number Publication date
FR3052452A1 (cg-RX-API-DMAC10.html) 2017-12-15
LT3468974T (lt) 2020-04-10
RS60029B1 (sr) 2020-04-30
JP2019517556A (ja) 2019-06-24
PL3468974T3 (pl) 2020-07-13
EA201892838A1 (ru) 2019-06-28
CA3027014C (en) 2021-01-05
ECSP18090144A (es) 2019-01-31
SV2018005791A (es) 2019-01-16
CO2018013210A2 (es) 2018-12-28
DK3468974T3 (da) 2020-05-11
UY37288A (es) 2018-01-02
EP3468974A1 (en) 2019-04-17
PE20220567A1 (es) 2022-04-13
GEAP202014978A (en) 2020-06-10
ES2775789T3 (es) 2020-07-28
PH12018502515B1 (en) 2021-11-10
MX2018015216A (es) 2019-04-25
CN109311888A (zh) 2019-02-05
AR108706A1 (es) 2018-09-19
MD3468974T2 (ro) 2020-05-31
JP6928005B2 (ja) 2021-09-01
HUE049507T2 (hu) 2020-09-28
CY1122870T1 (el) 2021-05-05
MY196562A (en) 2023-04-19
WO2017212012A1 (en) 2017-12-14
MA45222A (fr) 2019-04-17
EP3468974B1 (en) 2020-02-12
TW201802092A (zh) 2018-01-16
TN2018000410A1 (en) 2020-06-15
AU2017277734A1 (en) 2018-12-20
DOP2018000270A (es) 2019-05-15
RU2018147430A3 (cg-RX-API-DMAC10.html) 2020-07-10
NI201800132A (es) 2019-04-08
UA123794C2 (uk) 2021-06-02
TWI620750B (zh) 2018-04-11
IL263463B (en) 2021-01-31
EA037211B1 (ru) 2021-02-19
SI3468974T1 (sl) 2020-07-31
CU20180145A7 (es) 2019-07-04
SG11201810629QA (en) 2018-12-28
MA45222B1 (fr) 2020-04-30
US20190144448A1 (en) 2019-05-16
PT3468974T (pt) 2020-03-25
NZ748946A (en) 2025-06-27
ME03670B (en) 2020-10-20
CN109311888B (zh) 2021-09-14
AU2017277734B2 (en) 2021-07-01
US11046681B2 (en) 2021-06-29
RU2018147430A (ru) 2020-07-10
IL263463A (en) 2019-01-31
CR20180564A (es) 2019-03-04
FR3052452B1 (fr) 2018-06-22
PH12018502515A1 (en) 2019-09-30
CL2018003474A1 (es) 2019-05-24
HRP20200361T1 (hr) 2020-06-12
KR20190016106A (ko) 2019-02-15
GEP20207160B (en) 2020-10-12
MX374794B (es) 2025-03-06
RU2743163C2 (ru) 2021-02-15
CA3027014A1 (en) 2017-12-14

Similar Documents

Publication Publication Date Title
BR112018075284A2 (pt) derivados de piperidinila substituída por (hetero)arila, processo para sua preparação e composições farmacêuticas contendo-os
BR112017027831A2 (pt) derivados de hidroxiácido, um processo para sua preparação e composições farmacêuticas contendo-os
BR112018014536A2 (pt) derivados de amônio, um processo para sua preparação e composições farmacêuticas contendo os mesmos
DOP2018000270A (es) Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
BR112017027414A2 (pt) Derivados hidroxiéster, processo para prepará- los e composições farmacêuticas os contendo
BR112016017996A2 (pt) 6-heteroariloxi- or 6-ariloxi-quinolina-2-carboxamidas e método de uso
MX381707B (es) Nuevos derivados biciclicos, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
EA201401292A3 (ru) Новые тиенопиримидиновые производные, способ их получения и фармацевтические композиции, содержащие их
EA201890123A1 (ru) Новые аминокислотные производные, способ их получения и фармацевтические композиции, содержащие их
BR112018075939A2 (pt) compostos heterocíclicos como antibacterianos
BR112019000290A2 (pt) pró-fármacos de fósforo dos estimuladores da scg
BR112016002724A2 (pt) composto, processo para a preparação de um composto, composição farmacêutica
BR112015023560A8 (pt) Novos derivados de acrilamida como agentes antimaláricos
BR112015021432A2 (pt) compostos antivirais
BR112018071742A2 (pt) processo para a preparação de compostos herbicidas de piridinilimidazolona
PY1736656A (es) Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements